Intro; Preface; Contents; About the Editors; Chapter 1: Esophagogastric Junction (EGJ) Carcinoma: An Updated Review; 1.1 Introduction; 1.2 Classification; 1.3 Epidemiology and Risk Factors; 1.3.1 GERD and Barrett's Metaplasia; 1.3.2 Obesity; 1.3.3 Helicobacter pylori; 1.3.4 Tobacco Smoking; 1.3.5 Alcohol Consumption; 1.3.6 Dietary Factors; 1.3.7 Genetic and Molecular Studies; 1.4 Clinical Presentation; 1.5 Investigations; 1.5.1 Upper GI Endoscopy; 1.5.2 Endoscopic Ultrasound (EUS); 1.5.3 CT Scan; 1.5.4 PET-CT Scan; 1.5.5 Staging Laparoscopy and Peritoneal Lavage Cytology; 1.6 Staging

1.7 Treatment of Early Adenocarcinoma1.7.1 Rationale of Treatment; 1.7.2 Staging; 1.7.3 Endoscopic Treatment of Early Carcinoma; 1.7.4 Surgery for Early Carcinoma; 1.7.5 Comparison of Endoscopic Treatment and Surgery for Early Adenocarcinoma; 1.8 Treatment of Locally Advanced Tumours; 1.8.1 Principles of Surgery; 1.8.1.1 Longitudinal Resection Margins; 1.8.1.2 Circumferential Resection Margin (CRM); 1.8.1.3 Nodal Spread; 1.8.2 Surgical Approach Based on Siewert Type; 1.8.2.1 Siewert Type 1; Transthoracic Versus Transhiatal Esophagectomy

Extended Lymphadenectomy Versus Standard LymphadenectomyNeoadjuvant Therapy and Lymphadenectomy; Minimally Invasive Esophagectomy; 1.8.2.2 Siewert Type 2; The Enigma of Siewert Type 2 Tumours; Choosing a Surgical Procedure for Siewert Type 2 Tumours; 1.8.2.3 Siewert Type 3; Resection Margins for Siewert Type 3 Tumours; Nodal Spread of Siewert Type 3 Tumours; Lymphadenectomy for Siewert Type 3 Tumours; Extended Lymphadenectomy; 1.9 Multimodality Treatment; 1.9.1 Pre-/Perioperative Chemotherapy (Table 1.8); 1.9.2 Preoperative Chemoradiotherapy (Table 1.9); 1.9.3 Postoperative Chemoradiotherapy

1.9.4 Postoperative Chemotherapy1.9.5 Preoperative Chemoradiotherapy Versus Peri-/Preoperative Chemotherapy (Table 1.10); 1.9.6 Response-Guided Therapy; 1.9.7 How to Choose Multimodality Therapy for EGJ Carcinoma; 1.9.8 Upcoming Trials; 1.9.9 Targeted Therapy; 1.10 Palliation of Advanced EGJ Carcinoma; 1.10.1 Supportive Treatment; 1.10.2 Stents; 1.10.3 Concurrent Chemoradiotherapy; 1.10.4 Chemotherapy; 1.10.5 Targeted Therapy; 1.10.6 Other Interventions for Palliation; 1.10.7 How to Choose Good Palliation for Indian Patients; 1.11 Summary; References

Chapter 2: Superior Mesenteric Artery Syndrome2.1 Background; 2.1.1 Nutcracker Syndrome; 2.2 History; 2.3 Etiopathogenesis; 2.3.1 Embryological Basis of the SMAS; 2.3.1.1 SMA; 2.3.1.2 Rotation of the Developing Gut; 2.3.1.3 The SMA Angle; 2.3.1.4 The Suspensory Ligament of Treitz; Ligament of Treitz Variations; 2.3.1.5 Lie of the Duodenum; 2.4 Etiology; 2.4.1 Embryological Causes; 2.4.2 Acquired Causes; 2.4.2.1 Excessive Weight Loss due to Malnutrition [27]; 2.4.2.2 Following Spinal Surgery; 2.4.2.3 Following Restorative Proctocolectomy; 2.4.2.4 Following Bariatric Surgery